Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cannapharmarx Inc (OP: CPMD )

0.0080 -0.0020 (-20.00%)
Streaming Delayed Price Updated: 12:08 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,206,817
Open 0.0011
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0100
Today's Range 0.0001 - 0.0100
52wk Range 0.0007 - 0.0279
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CannapharmaRx Pays Off Convertible Notes
Via ACCESSWIRE
CannapharmaRx Receives First Purchase Order and Begins Shipment of Product
Via ACCESSWIRE

Performance

YTD
+515.38%
+515.38%
1 Month
-44.83%
-44.83%
3 Month
+220.00%
+220.00%
6 Month
+321.05%
+321.05%
1 Year
-20.00%
-20.00%

More News

Read More
CannaPharmaRx Completes First Harvests
Via ACCESSWIRE
CannaPharmaRx to Hold Investor Conference Call
Via ACCESSWIRE
Cannapharmarx Partners With ICAN To Expand Cannabis Distribution In Latin America
Via Benzinga
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Executes Multi-Year Supply Agreement with ICAN to Create Distribution Network in the Latin Americas
Via ACCESSWIRE
CannaPharmaRx CEO Provides Annual Update Message
Via ACCESSWIRE
CannaPharmaRx Achieves IMC-GAP and GACP Certifications Completing a Significant Milestone Towards Revenue Acceleration
Via ACCESSWIRE
CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with Cantek
Via ACCESSWIRE
Cannabis Industry Changes As Marijuana Rescheduling Looms
Via Benzinga
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Expands Board of Directors
Via ACCESSWIRE
Cannabis Movers & Shakers: Delaware's New Marijuana Commissioner And Latest Industry Appointments
Via Benzinga
CannaPharmaRx Appoints Dean Medwid as New CEO
Via ACCESSWIRE
CannaPharmaRx Signs Agreement with Nasha Genetics
Via ACCESSWIRE
CannaPharmaRx Signs Supply Agreement With Y.S.A For Up To $15M Annually Of Commercial Cannabis
Via Benzinga
CannaPharmaRx Signs Supply Agreement with Y.S.A Holdings for up to $15 Million Annually of Commercial Cannabis
Via ACCESSWIRE
New Leaf Ventures Enters Into Genetics Supply Agreement With CannaPharmaRX
Via Benzinga
CannaPharmRx, Inc. Completes Purchase of LTB Management, an E- Commerce and Financial Platform Company, and Launches New Corporate Website
Via ACCESSWIRE
CannaPharmRx, Inc. Adds to Revenue Streams by Purchasing E-Commerce and Financial Platform Company
Via ACCESSWIRE
CannaPharmaRx Evaluates Investigation into Market Manipulation and Potentially Illegal Trading of Stock
Via ACCESSWIRE
CannaPharmaRx Releases Year-in-Review Letter to Shareholders and Discusses Revenue Opportunities for 2023
Via ACCESSWIRE
CannaPharmaRx Receives Canada Revenue Agency (CRA) License As Final Step to Bringing Facility Into Production With Annual Revenues of Over $30 Million Expected
Via ACCESSWIRE
Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond
Via Newsfile
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 Million
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.